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ABSTRACT 
Objectives: The primary aim of this systematic review was to explore the strength of association 
between birthweight (BW) discordance and perinatal mortality in twin pregnancies; the secondary 
aim was to ascertain the contribution of gestational age and growth restriction in determining 
mortality in growth discordant twins. 
Methods: Medline, Embase, Cinahl and Clinicaltrials.gov databases were searched. Only studies 
reporting the risk of mortality in twin pregnancies affected compared to those not affected by 
weight discordance were included. The weight discordance cut-offs considered were ≥15%, ≥20%, 
≥25%, ≥30%. Meta-analyses using individual data random-effect logistic regression and meta-
analyses of proportion were used to analyse the data.  
Results: Twenty-two studies (10877 twin pregnancies) were included. In DC pregnancies, the 
overall risk of IUD, but not of NND, was higher in twins with ≥15% (OR: 9.8, 3.9-29.4), ≥20% 
(OR: 7.0, 95% CI 4.15-11.8), ≥25% (OR: 17.4, 95% CI 8.3-36.7) and ≥30% (OR: 22.9, 95% CI 
10.2-51.6) BW discordance compared to controls. For each cut-off of BW discordance explored, the 
smaller twin was at higher risk of mortality compared to the larger one.  
In MC twin pregnancies, twins discordant ≥20% (OR: 2.8, 95% CI 1.3-5.8) or ≥25% (OR: 3.2, 95% 
CI 1.49-6.67) were at higher risk of IUD, compared to controls once cases affected by twin-to twin 
transfusion syndrome were excluded. Twin pregnancies with ≥25% weight discordance were also at 
risk of NND (OR: 6.77, 95% CI 2.25-20.4). The risk of IUD was higher when considering only 
discordant pregnancies containing at least an SGA fetus. The overall risk of mortality was not 
different between the smaller and larger twin except for a weight discordance of ≥20%  
Conclusion: DC and MC twin pregnancies discordant for fetal growth are at higher risk of IUD but 
not NND compared to concordant twins. The risk of IUD in discordant DC and MC twins is higher 
when at least one fetus is SGA.  
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INTRODUCTION 
Birthweight (BW) discordance is one of the major determinants of perinatal outcome in twin 
pregnancies irrespective of chorionicity1. Although certain degree of growth discordance may 
represent a normal physiological variation, perinatal mortality and morbidity are known to be 
increased with higher degrees of discordance2-13. In view of this association, it is routine obstetric 
practice to regularly screen twin pregnancies by ultrasound to evaluate the degree of inter-twin fetal 
growth discordance, given its overall good diagnostic accuracy in identifying these disorders14. 
Despite this, there are still controversies on the actual role of discordant fetal growth in determining 
perinatal mortality. Although some studies have reported an increased risk for mortality in growth-
discordant twins, others did not find any association. Heterogeneity in the study design, inclusion of 
fetuses affected by anomalies and lack of stratification of the analysis according to gestational age 
at birth and chorionicity are likely to explain such inconsistencies. Furthermore, a multitude of 
weight discordance cut-offs have been suggested to be associated with mortality, but it is yet to be 
established which one provides the best combination of sensitivity and specificity.  
Finally, although the association between BW discordance and mortality outcome has been reported 
to be independent of chorionicity, antenatal management of discordant twins should be tailored 
according to chorionicity in view of higher risk of mortality and adverse neurological outcome 
observed in case of co-twin death in monochorionic (MC) pregnancies15. 
The primary aim of this systematic review was to explore the strength of association between BW 
discordance and perinatal mortality in twin pregnancies; the secondary aim was to ascertain the 
contribution of gestational age and growth restriction in determining mortality in discordant twins. 
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METHODS 
Protocol, eligibility criteria, information sources and search 
This review was performed according to a priori designed protocol recommended for systematic 
reviews and meta-analysis16-18. Medline, Embase, Cinahl and Clinicaltrials.govdatabases were 
searched electronically on the 18.12.2016 utilizing combinations of the relevant medical subject 
heading (MeSH) terms, key words, and word variants for “birthweight discordance” and “outcome” 
(Supplementary Table 1). The search and selection criteria were restricted to English language. 
Reference lists of relevant articles and reviews were hand searched for additional reports. Prisma 
and MOOSE guidelines were followed19-21.  
The study was registered with the PROSPERO database (Registration number: CRD42016043062). 
 
Study selection, data collection and data items 
The primary outcomes explored in the present systematic review were: 
• Intra-uterine death (IUD) 
• Neonatal death (NND) 
• Perinatal death (PND) 
IUD was defined as the death of at least one twin from 20 weeks of gestation onwards, while NND 
as the death of at least one of the new-borns up to 28 days of life, and perinatal death (PND) was 
defined as the occurrence of IUD and NND. 
 
The secondary outcomes were the occurrence of IUD, NND and PND stratified according to the 
gestational age at death and birthweight of the twins. For the purpose of this analysis, twin 
pregnancies were divided into those in which IUD (or NND in case twins were delivered) occurred 
before and after 34 weeks of gestation and into SGA (twin pregnancy with BW of at least one twin 
<10 percentile and appropriate for gestational age (AGA) (both twins with BW ≥10 percentile). 
Finally, we assessed the risk of IUD, NND and PND in the smaller vs larger twin. 
 
All the observed outcomes were reported for MC and DC twins separately. The reason for this 
choice was based upon the fact that, although the association between discordant growth and 
mortality has been reported to be independent from chorionicity, it is taken into account while 
managing twins with discordant growth. Furthermore, in MC twins, we reported the risk of 
mortality after exclusion of cases affected by twin-to-twin transfusion syndrome (TTTS). 
BW discordance was defined as the percentage of discrepancy in birthweight between the large and 
the smaller twin and calculated by the following equation (larger actual weight –smaller actual 
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weight)/ larger actual weight)1. We stratified the analysis according to the most commonly reported 
cut-offs of BW discordance (≥15%, ≥20%, ≥25% and ≥30%).  
 
Only studies reporting the risk of mortality in discordant vs concordant twins and from which the 
raw numbers to calculate the risk of every explored outcome could be extrapolated were considered 
suitable for the inclusion. Studies including cases with fetal anomalies were excluded in view of the 
higher risk of mortality in twins affected by structural or chromosomal anomalies. Studies reporting 
the outcome of high order multiple gestations reduced to twins as well studies exclusively reporting 
cases treated with intra-uterine therapy (laser treatment or cord ligation) were excluded. Finally, 
studies including cases with TTTS were also excluded. Only full text articles were considered 
eligible for the inclusion. Case reports, conference abstracts and case series with fewer than 3 cases 
were excluded to avoid publication bias. Furthermore, studies published before 2000 were not 
included as advances in management of twin pregnancies make them less relevant. 
Two authors (FD, DB) reviewed all abstracts independently. Agreement regarding potential 
relevance was reached by consensus; full text copies of those papers were obtained and the same 
two reviewers independently extracted relevant data regarding study characteristics and pregnancy 
outcome. Inconsistencies were discussed by the reviewers and consensus reached or by discussion 
with a third author. If more than one study was published on the same cohort with identical 
endpoints, the report containing the most comprehensive information on the population was 
included to avoid overlapping populations. For those articles in which information was not reported 
but the methodology was such that this information would have been recorded initially, the authors 
were contacted. 
Quality assessment of the included studies was performed using the Newcastle-Ottawa Scale (NOS) 
for case-control studies; according to NOS, each study is judged on three broad perspectives: the 
selection of the study groups; the comparability of the groups; and the ascertainment outcome of 
interest22. Assessment of the selection of a study includes the evaluation of the representativeness of 
the exposed cohort, selection of the non-exposed cohort, ascertainment of exposure and the 
demonstration that outcome of interest was not present at start of study. Assessment of the 
comparability of the study includes the evaluation of the comparability of cohorts based on the 
design or analysis. Finally, the ascertainment of the outcome of interest includes the evaluation of 
the type of the assessment of the outcome of interest, length and adequacy of follow-up. According 
to NOS a study can be awarded a maximum of one star for each numbered item within the Selection 
and Outcome categories. A maximum of two stars can be given for Comparability22. 
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Statistical analysis 
Overall, we evaluated the association between weight discordance and mortality (IUD, NND and 
PND) in twin pregnancies. The resulting meta-analyses were stratified according to chorionicity 
(MC or DC) and degree of weight discordance (≥15%; ≥20%; ≥25%; or ≥30%). Furthermore, all 
analyses were carried out four times: (a) including all pregnancies; (b) including only pregnancies 
≥34 weeks; (c) including only pregnancies <34 weeks; (d) including only those pregnancies with ≥1 
SGA twin; (e) including only those pregnancies with both AGA twins. 
Some of the included observational case-control studies reported zero events in one or both 
compared groups, and the exposed and unexposed groups were frequently unbalanced. In such a 
case, the best performing methods are the Mantel-Haenszel odds ratio without zero-cell continuity 
corrections, logistic regression and an exact method23,24. Mantel-Haenszel odds ratios cannot be 
computed in studies reporting zero events in both groups, the exclusion of which may however 
cause a relevant loss of information and the potential inflation of the magnitude of the pooled 
exposure effect. Therefore, to keep all studies in the analyses, we performed all meta-analyses using 
individual data random-effect logistic regression with single study as the cluster unit. The pooled 
datasets with individual data were reconstructed using published 2X2 tables. When one of the 
overall pooled arms showed no events, we used exact logistic regression. If a meta-analysis 
included only one study in the comparison, the related odds ratio was computed from the raw data 
of the single study. 
Some of the comparisons showed an extreme imbalance in the success rate between the groups 
being compared. Besides the computational issues, in such cases the odds ratios may be of limited 
interest and sensitivity and specificity could be more informative. We thus computed the overall 
sensitivity and specificity (and related 95% confidence intervals) for each comparison using the 
efficient-score method (corrected for continuity) described by Newcombe25,26. 
Finally, we performed meta-analyses of proportions to estimate the pooled rates of IUD, NND and 
PND of discordant twins, concordant twins, SGA twins and AGA twins, respectively. Proportion 
meta-analyses were not meaningful when only one study could be included, and were performed 
using a random-effect model to account for the inter-study heterogeneity. 
The potential publication bias was assessed either graphically, displaying the odds ratios of 
individual studies vs the logarithm of their standard errors (funnel plots), and formally, using 
Egger's regression asymmetry test27. As the power of formal testing for funnel plot asymmetry is 
too low when less than 10 studies are included into a meta-analysis, we were able to evaluate the 
publication bias only for the meta-analyses reported in Supplementary Graphs 1-328.  
All analyses were carried out using STATA, version 13.1 (Stata Corp., College Station, TX, 2013). 
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RESULTS 
General characteristics 
808 articles were identified, 210 were assessed with respect to their eligibility for inclusion 
(Supplementary Table 2) and 22 studies were included in the systematic review (Table 1, Figure 1) 
(14-25) 29-51. These 22 studies included 10877 twin pregnancies.  
In DC pregnancies, the prevalence of BW discordance ≥15%, 20%, 25% and 30% was 31.0% (95% 
CI 29.0-33.1), 23.4% (95% CI 22.4-24.5), 10.7% (95% CI 9.6-11.9) and 5.9% (95% CI 4.8-7.0) 
respectively, while the corresponding figures in MC twins were 44.2% (95% CI 39.1-49.4), 26.7% 
(95% CI 24.7-28.7), 16.5% (95% CI 14.6-18.5) and 12.6% (95% CI 8.6-17.6). 
However, in view of the fact that some included studies were case controlled series, the figures 
reported here may not represent the actual prevalence of the different cut-offs of birthweight 
discordance in twin pregnancies. 
Results of quality assessment of the included studies using Newcastle-Ottawa Scale (NOS) are 
presented in Table 2. Most of the included studies showed an overall good score regarding the 
selection and comparability of the study groups, and for ascertainment of the outcome of interest. 
The main weaknesses of these studies were their retrospective design, small sample size, different 
gestational ages at scan, large heterogeneity in the definition of abnormal cut-offs for discordance 
and lack of information on prenatal management of twins affected by weight discordance. 
Furthermore, not all the included studies were matched case-control series, thus making entirely 
possible for other co-factors to affect the robustness of the results. 
 
Synthesis of the results 
DC twin pregnancies 
BW discordance ≥15% 
Two studies (2001 pregnancies) explored the risk of mortality in twin with a BW discordance 
≥15%31,37. The risk of PND was higher in discordant vs concordant twins with an OR of 3.6 (95% 
CI 2.0-6.5) and this was mainly due to the increased risk of IUD (OR: 9.8, 3.9-29.4) while there was 
no risk of NND in DC twins with BW discordance ≥15% compared to controls (Table 3). 
When stratifying the analysis according to the gestational age, the risk of IUD after 34 weeks of 
gestation was higher in discordant compared to concordant twins (OR: 6.2, 95% CI 2.0-22.6), but 
there was no difference in the risk of NND.  
Furthermore, the risk of IUD was higher when at least one twin was SGA (OR: 12.0, 95% CI 2.9-
106), while there was no difference in appropriately grown discordant twins (p= 0.8). Likewise, the 
risk of NND was higher in discordant SGA twins compared to SGA concordant twins, with an OR 
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of 9.2 (95% CI 2.8-47.7) (Table 3). Proportions for the occurrence of mortality in discordant and 
concordant twin pairs are reported in Supplementary Table 3. 
 
BW discordance ≥20% 
Eleven studies including 6795 twin pregnancies explored the risk of mortality in discordant twins 
≥20%compared to controls29,31,33,34-37,41,43,44,48,49. The risk of PND was higher in DC twin 
pregnancies with a BW ≥20%, (OR 6.0, 95% CI 3.5-10.1) and this was due to the higher risk of 
IUD (OR: 7.0, 95% CI 4.2-11.8) rather than NND (Table 4). The risk of IUD in twin pregnancies 
with a BW≥20% was higher both before (OR: 5.4, 95% CI 2.1-13.8) and after (OR: 7.3, 95% CI 
3.2-16.2) 34 weeks of gestation and in twin pairs containing at least an SGA fetus (OR: 12.7, 95% 
CI 5.6-28.7) (Table 4). 
 
BW discordance ≥25% 
Five studies including 2773 twin pregnancies explored the risk of mortality in discordant twins 
(≥25%) compared to controls31,37,45,47,50. The risk of PND was higher in DC twins with a BW 
discordance compared to controls (OR: 8.4, 95% CI 4.9-14.3). The association between discordant 
growth ≥25% and PND was due to the higher risk of IUD (OR: 17.4, 95% CI 8.3-36.7), as there 
was no difference in NND between concordant and discordant DC twins (Table 5). 
The association between BW discordance ≥25% and IUD in DC twins persisted when stratifying 
the analysis according to the gestational age (OR: 21.2, 95% CI 7.2-69.7 for twins ≥34 and 
OR:10.0, 95% CI 2.7-44.8 for twins <34 weeks of gestation, respectively) and when at least an 
SGA twin was present (OR: 19.4, 95% CI 6.4-78.4),but there was no difference when both twins 
were AGA (Table 5).Pooled proportions for the occurrence of mortality in discordant and 
concordant twin pairs are reported in Supplementary Table 3. 
 
BW discordance ≥30% 
Only one study explored the risk of mortality in non-anomalous twins affected by BW discordance 
≥30%31. The risk of PND was higher in discordant twin pregnancies with an OR of 13.8 (95% CI 
7.1-26.5) and it was due to the higher risk of IUD (OR: 22.9, 95% CI 10.2-51.6), as there was no 
difference in NND (Table 6). The association between BW discordance ≥30% and IUD persisted 
when considering only twins born ≥34 (OR: 21.2, 95% CI 6.8-63.9) or <34 (OR: 13.6, 95% CI 3.7-
54.3) weeks of gestation and when at least one SGA fetus was present in the twin pair (OR: 10.7, 
95% CI 4.1-31.3). There was no difference in IUD when considering only AGA twins. The risk of 
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NND was higher in discordant twins < 34 weeks and in those SGA (OR of 13.2, 95% CI 1.3-66.8 
and 13.1, 95% CI 1.0-691 respectively) (Table 6). 
 
 
MC twin pregnancies 
BW discordance ≥15% 
One study (302 twin pregnancies) explored the risk of mortality in discordant vs concordant MC 
twins when a cut-off of 15% was applied to define discordance31. When excluding pregnancies 
affected by TTTS, the overall risk of either IUD, NND and PND was not significantly higher in 
pregnancies affected compared to those not affected by BW discordance. However, there was a 
higher risk of IUD ≥34 weeks of gestation (OR: 10.5, 95% CI 1.00-521) in discordant twins 
compared to controls and in case a SGA twin was present (OR: 8.0, 95% CI 1.04-355), while there 
was no difference in the risk of NND (Table 7). Proportions for the occurrence of mortality in 
discordant and concordant twin pairs are reported in Supplementary Table 4.  
 
BW discordance ≥20% 
Six studies including 1286 MC twin pregnancies explored the risk of mortality in twins with BW 
≥20% compared to controls (Table 8) 29,31,34,39,44,46. The risk of PND was higher in MC discordant 
twins compared to controls with an OR of 2.3 (95% CI 1.2-4.5). The risk of IUD was higher in 
discordant compared to concordant twins (OR: 2.8, 95% CI 1.3-5.8), while there was no difference 
in the risk of NND between the two groups. When stratifying the analysis according to the 
gestational age, the risk of IUD was higher in twins ≥34 weeks of gestation (Table 8). Furthermore, 
there was an increased risk of IUD when at least one SGA fetus was present in the discordant pair.   
 
BW discordance ≥25% 
Five studies (993 MC twin pregnancies) explored the risk of mortality when a 25% cut-off was 
applied to define discordance31,35,38,42,45. The risk of PND was higher in discordant compared to 
concordant MC twin pairs with an OR of 3.2 (95% CI 1.9-5.4). The risk of IUD and NND was 
higher in discordant twins with an OR of 3.2 (95% CI 1.49-6.67) and 4.7 (95% CI 1.8-12.4) (Table 
9). The risk of IUD was higher when considering only discordant pregnancies containing at least an 
SGA fetus (OR: 4.6, 95% CI 1.68-12.8), while there was no difference in the occurrence of NND. 
Pooled proportions for the occurrence of mortality in discordant and concordant twin pairs are 
reported in Supplementary Table 4. 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
BW discordance ≥30% 
Only one study including 303 MC twin pregnancies explored the risk of mortality in non-
anomalous discordant twins ≥30%31. In view of the small number of included cases and even 
smaller number of events it was not possible to perform a meaningful risk stratification. The risk of 
IUD was higher in discordant twin pregnancies compared to controls, with an OR of 14.3 (95% CI 
1.1-136), while this association did not persist when considering only cases < 34 weeks of gestation 
(Table 10). 
 
Smaller vs larger twin 
Table 11 shows the risk of mortality in the smaller vs larger twin in DC pregnancies. For each cut-
off of BW discordance explored in the present review, the smaller twin was at higher risk of IUD 
but not NND compared to the larger one.  
The assessment of the risk of mortality between the smaller and the larger twin in MC twins was 
affected by the small number of included cases and events. The risk of PND was higher in the 
smaller twin with ≥20% risk of discordance (OR: 4.2, 95% CI 1.7-15.1) (Table 12). Pooled 
proportions for the occurrence of mortality in the smaller and larger twins are reported in 
Supplementary Table 5 and 6. 
 
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rti
cl
e
 
DISCUSSION 
Main findings 
The findings from this systematic review showed that DC and MC twin pregnancies discordant for 
fetal growth were generally at higher risk of IUD but not NND compared to concordant twins. The 
risk of IUD in discordant twins was higher when at least one fetus was SGA, while it was not 
increased when considering only AGA twins. When comparing the smaller and the larger twin, the 
risk of IUD was usually higher in the smaller than in the larger twins in DC, while in MC there was 
an increased risk of PND in the smaller twin for a discrepancy ≥20%.  
 
Strengths and limitations 
The small number of cases in some of the included studies, their retrospective non-randomized 
design, different definitions of IUD and NND among the included studies, dissimilarity of the 
populations (due to various inclusion criteria), use of estimated fetal weight as a proxy for BW 
discordance in some of the included studies and lack of standardized criteria for the antenatal 
management of discordant twin pregnancies represent the major limitations of this systematic 
review. Assessment of the potential publication bias was also problematic because of the nature of 
the outcome evaluated (outcome rates, with the left-side limited to a value of zero), which limits the 
reliability of funnel plots, and because of the scarce number of individual studies, which strongly 
limits the reliability of formal tests. Not all the included studies were case-control series reporting 
matched populations and it might be entirely possible that the presence and degree of association 
between BW discordance and mortality might have been affected by several co-factors which were 
not balanced between cases affected and not affected by discrepancy in twin size, such as 
gestational age at birth, severity of growth restriction and maternal co-morbidities. 
Another major limitation of this systematic review was the differences in the antenatal management 
of discordant twins. Furthermore, the interval between the occurrence of IUD and birth was not 
reported in the large majority of the included studies; this is fundamental because a larger interval 
between IUD and birth may significantly affect the degree of weight discordance and consequently 
the magnitude of its effect on the outcomes explored in the present review. Finally, the majority of 
the included studies did not stratify the analysis according to the gestational age at birth or detection 
of discordant growth and birthweight centile of the twins, thus considerably reducing the number of 
cases included in these sub-analyses and, consequently, their power.  
Despite these limitations, the present review represents the most comprehensive published estimate 
of the investigated outcomes in twin pregnancies affected by discordant growth. 
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Implications for clinical practice 
Management of twin pregnancies affected by weight discordance is challenging. There is no 
randomized trial assessing the different management options (expectant management vs delivery) 
when a discrepancy in fetal size is detected during pregnancy. Furthermore, there is still no 
consensus on which cut-off of discordance should be adopted in clinical practice.  
 
In the present systematic review, BW discordance was associated with an increased risk of IUD and 
such association was independent from gestational age, with increased risk of mortality either 
before and after 34 weeks of gestation. Conversely, twins discordant for fetal growth were not at 
higher risk of NND, except for a discrepancy of ≥20% in MC pregnancies. The generally lack of 
association between BW discordance and NND confirms the findings from singleton pregnancies, 
where gestational age at birth represents the main risk factor for neonatal mortality51. In this 
scenario, weight discordance per se should not be used as a primary indication for delivery, and 
other factors such as gestational age at assessment, chorionicity and fetal Dopplers should be 
considered when managing discordant twins52.  
 
The association between discordant growth and mortality was stronger when considering twin 
pregnancies containing at least one SGA fetus, while the risk was not increased when both twins 
were AGA.  It has been recently suggested that discordant growth in appropriately grown twins may 
represent a risk factors for adverse perinatal outcome, irrespective of fetal weight29. In the present 
systematic review, we did not find an increased risk of either IUD and NND in appropriately grown 
discordant twins, although the small number of cases included in this analysis might have 
underestimated this association. Therefore, these results should be interpreted with caution and 
further evidence is needed to ascertain whether discordant AGA twins should be considered at high 
risk of perinatal compromise. Until then, AGA discordant twins should be still considered at risk of 
adverse perinatal outcome and worth of close follow-ups in order to detect signs of fetal 
compromise, such as abnormal growth trend and Doppler. 
 
When comparing the smaller and larger twin, the risk of IUD was higher in the smaller twin in DC 
twins while there was no difference in MC pregnancies. The pathophysiology of discordant growth 
is different in MC and DC twin pregnancies; while in DC discordant growth is mainly caused by 
discordant placental size and function, in MC the magnitude of discordant growth is influenced not 
only by abnormal placental sharing but also by the direction of blood flow interchange through the 
placental anastomoses, and this might partially explain why the risk of mortality was similar 
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between the smaller and larger twin. Furthermore, due to the presence of such anastomoses, single 
IUD in a MC pair may lead to co-twin death in a considerable number of cases15. 
 
Large prospective studies aiming at assessing the optimal management options and the outcome of 
discordant twins according to the degree of weight discrepancy, gestational age at assessment, 
Doppler findings and chorionicity are needed to elucidate the actual association between discordant 
growth and perinatal mortality in twin pregnancies. 
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Table 1. General characteristics of the included studies. Gestational age (in case of IUD) or days at outcome is reported between parentheses. 
Author Year Country Study design Period 
considered 
Chorionicity Twin 
pregnancies 
Mortality Cut-off (s) explored 
Harper29 2013 United States Retrospective 1990-2008 DC, MC 1145 IUD (≥ 24w) 20% 
Lopriore30 2012 The Netherlands Retrospective 2002-2011 MC 47 NND (NS) 25% 
D'Antonio31 2012 United Kingdom Retrospective 2000-2010 DC, MC 2161 IUD (≥ 24w), NND (28d) 15%; 20%; 25%; 30% 
Nakayama32 2012 Japan Retrospective 2004-2010 MC 198 NND (28d) 25% 
Suzuki33 2012 Japan Retrospective 2002-2010 DC, MC 832 IUD (≥ 22w) 20% 
Mahony34 2011 Ireland Retrospective 1997-2006 DC, MC 1094 IUD (≥ 24w) 20% 
Weisz35 2011 Israel Prospective 2004-2008 MC 128 IUD (≥ 24w), NND (NS) 25% 
Breatnach36 2011 Ireland Prospective 2007-2009 DC, MC 963 PND (≥ 24w to 28d) 18% 
Diaz-Garcia37 2010 France/Spain Retrospective 2004-2007 DC, MC 283 PND (≥ 22w to 8d) 15%; 20%; 25% 
Smith38 2010 United States Retrospective 2001-2008 MC 270 IUD (≥ 24w), NND (NS) 25% 
De Paepe39 2010 United States Retrospective 2001-2009 MC 216 IUD 20% 
Shrim40 2010 Canada/Israel Retrospective 2001-2007 MC 93 IUD (≥ 25w), NND (28d) 20% 
Alam Machado41 2009 Brazil Retrospective 1998-2004 DC, MC 151 NND (7d) 20% 
Lewi42 2008 Belgium/Germany/Spain Prospective 2002-2007 MC 178 IUD (≥ 24w), NND (NS) 25% 
Appleton43 2007 Portugal Retrospective 1989-2002 DC, MC 230 IUD (≥ 34w), NND (NS) 20% 
Hack44 2007 The Netherlands Retrospective 1995-2004 DC, MC 1305 IUD (≥ 20w), NND (7d) 20% 
Acosta-Rojas45 2007 Spain Prospective NS DC, MC 219 IUD (≥ 20w), NND (28d) 25%*  
Cordero46 2005 United States Retrospective 1990-2004 MC 74 IUD (≥ 20w), NND (1d) 20% 
Leduc47 2005 Canada Retrospective 1994-2002 DC, MC 503 NND (1m) 25% 
Adegbite48 2004 United Kingdom Retrospective 1991-1997 DC, MC 154 NND (NS) 20% 
Geipel49 2002 Germany Retrospective 1998-2001 DC 256 IUD (≥ 24w) 20% 
Victoria50 2001 United States Retrospective 1993-1995 MC, DC 377 PND (≥ 24w) a 25% 
*: and 1 twin EFW <10th pc for GA. 
W: weeks of gestation; d: days; m: months; NS: not stated 
a:  time at neonatal death not reported
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Table 2. Quality assessment of the included studiesaccording to Newcastle-Ottawa Scale (NOS) a 
study can be awarded a maximum of one star for each numbered item within the Selection and 
Outcome categories. A maximum of two stars can be given for Comparability. 
 
Author Year Selection Comparability Outcome 
Harper29 2013    
Lopriore30 2012   
D'Antonio31 2012    
Nakayama32 2012    
Suzuki33 2012    
Mahony34 2011    
Weisz35 2011    
Breatnach36 2011    
Diaz-Garcia37 2010   
Smith38 2010    
De Paepe39 2010    
Shrim40 2010    
Alam Machado41 2009   
Lewi42 2008    
Appleton43 2007    
Hack44 2007    
Acosta-Rojas45 2007   
Cordero46 2005    
Leduc47 2005    
Adegbite48 2004    
Geipel49 2002    
Victoria50 2001    
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Table 3. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in dichorionic twins 
with birthweight discordance ≥15% (discordant twins) versus dichorionic twins without birthweight discordance (concordant twins), overall and by 
selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
 IUD in discordant vs concordant twins       
- All pregnancies 1 (1859)31 (25/569 vs 6/1290) 9.83 (3.90-29.4) <0.001 80.6 (61.9-91.9) 70.2 (68.1-72.3) 
- Pregnancies ≥34 weeks 1 (1618)31 (12/459 vs 5/1159) 6.20 (2.01-22.6) <0.001 70.6 (44.0-88.6) 72.1 (69.8-74.3) 
- Pregnancies <34 weeks 1 (253)31 (13/110 vs 8/143) 2.26 (0.83-6.53) 0.07 61.9 (38.7-81.0) 58.2 (51.5-64.6) 
- ≥ 1 SGA twin 1 (839)31 (22/411 vs 2/428) 12.0 (2.92-106) <0.001 91.7 (71.5-98.5) 52.3 (48.8-55.7) 
- Both AGA twins 1 (1020)31 (3/158 vs 4/862) 4.15 (0.60-24.7) 0.8 42.9 (11.8-79.8) 84.7 (82.3-86.8) 
       
NND in discordant vs concordant twins       
- All pregnancies 1 (1859)31 (4/569 vs 13/1290) 0.69 (0.16-2.26) 0.5 23.5 (7.8-50.2) 69.3 (67.2-71.4) 
- Pregnancies ≥34 weeks 1 (1618)31 (1/459 vs 5/1159) 0.50 (0.01-4.52) 0.5 16.7 (0.9-63.5) 71.6 (69.3-73.8) 
- Pregnancies <34 weeks 1 (253)31 (3/110 vs 1/143) 3.98 (0.31-210) 0.2 75.0 (21.9-98.7) 57.0 (50.6-63.2) 
- ≥ 1 SGA twin 1 (839)31 (3/411 vs 1/428) 3.14 (0.25-165) 0.3 75.0 (21.9-98.7) 51.1 (47.7-54.6) 
- Both AGA twins 1 (1020)31 (1/158 vs 12/862) 0.45 (0.01-3.09) 0.4 7.7 (0.4-37.9) 84.4 (81.9-86.6) 
       
PND in discordant vs concordant twins       
- All pregnancies 2 (2001)31,37 (30/621 vs 19/1380) 3.64 (2.03-6.52) <0.001 61.2 (46.2-64.4) 69.7 (67.6-71.7) 
- Pregnancies ≥34 weeks 1 (1618)31 (13/459 vs 10/1159) 1.75 (0.79-3.76) 0.12 56.5 (34.9-76.1) 72.0 (69.7-74.2) 
- Pregnancies <34 weeks 1 (253)31 (16/110 vs 9/143) 2.53 (1.01-6.78) 0.03 64.0 (42.6-81.3) 58.8 (52.1-65.2) 
- ≥ 1 SGA twin 1 (839)31 (25/411 vs 3/428) 9.17 (2.76-47.7) <0.001 89.3 (70.6-97.2) 52.4 (48.9-55.9) 
- Both AGA twins 1 (1020)31 (4/158 vs 16/862) 1.37 (0.33-4.33) 0.6 20.0 (6.6-44.3) 84.6 (82.8-86.7) 
OR = Odds Ratio;   CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single 
study. 
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Table 4. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in dichorionic twins 
with birthweight discordance ≥20% (discordant twins) versus dichorionic twins without birthweight discordance (concordant twins), overall and by 
selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
IUD in discordant vs concordant twins       
- All pregnancies 7 (5675)29,31,33,34,43,44,49 (40/1331 vs 24/4344) 7.0 (4.15-11.8) <0.001 62.5 (49.5-74.0) 77.0 (75.9-78.0)
- Pregnancies ≥34 weeks 4 (3664)31,34,43,44 (20/1036 vs 10/2628) 7.25 (3.24-16.2) <0.001 66.7 (47.1-82.1) 72.0 (70.5-73.5)
- Pregnancies <34 weeks 2 (972)31,34 (13/225 vs 7/747) 5.37 (2.09-13.8) <0.001 65.0 (40.9-83.7) 77.7 (74.9-80.3) 
- ≥ 1 SGA twin 2 (1073)31,33 (40/367 vs 7/706) 12.7 (5.60-28.7) <0.001 85.1 (71.1-96.3) 68.1 (65.2-70.9) 
- Both AGA twins 4 (2448)29,31,33 (4/161 vs 24/2287) 2.51 (0.85-7.40) 0.09   
       
NND in discordant vs concordant twins       
- All pregnancies 5 (3385)31,41,43,44,48 (8/1021 vs 29/2364) 0.90 (0.40-2.04) 0.8 21.6 (10.4-38.7) 69.7 (68.2-71.3) 
- Pregnancies ≥34 weeks 3 (2945)31,43,44 (1/892 vs 8/2053) 0.29 (0.04-2.30) 0.2 11.1 (0.6-49.3) 69.7 (67.9-71.3) 
- Pregnancies <34 weeks 2 (328)31,34 (4/101 vs 15/227) 0.59 (0.19-1.84) 0.4 21.1 (7.0-46.1) 68.6 (63.1-73.7) 
- ≥ 1 SGA twin 2 (1002)31,33 (3/292 vs 3/710) 2.45 (0.49-12.2) 0.3 50.0 (13.9-86.1) 71.0 (68.0-73.8) 
- Both AGA twins 2 (1178)31,43 (0/82 vs 15/1096) 0.63 (0.0-3.75)* 0.7 0.0 (0.0-25.3) 92.9 (91.3-94.3) 
       
PND in discordant vs concordant twins       
- All pregnancies 5 (4127)31,36,37,43,44 (38/1176 vs 25/2951) 5.98 (3.53-10.1) <0.001 60.3 (47.2-72.2) 72.0 (70.6-73.4) 
- Pregnancies ≥34 weeks 3 (2945)31,43,44 (16/892 vs 16/2053) 3.34 (1.56-7.15) 0.002 50.0 (32.2-67.8) 70.0 (68.2-71.6) 
- Pregnancies <34 weeks 1 (253)31 (14/81 vs 11/172) 3.06 (1.21-7.83) 0.007 0.56 (35.3-75.0) 70.6 (64.2-76.3) 
- ≥ 1 SGA twin 1 (839)31 (24/270 vs 4/569) 13.9 (4.70-55.5) <0.001 85.7 (66.4-95.3) 69.7 (66.3-72.3) 
- Both AGA twins 1 (1020)31 (3/65 vs 17/955) 2.67 (0.49-9.58) 0.11 15.0 (3.9-38.9) 93.8 (92.1-95.2) 
OR = Odds Ratio; CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age.    
* Exact logistic regression, as no logistic regression model was possible due to zero event in the exposed group.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single study. 
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Table 5. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in dichorionic twins 
with birthweight discordance ≥25% (discordant twins) versus dichorionic twins without birthweight discordance (concordant twins), overall and by 
selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
IUD in discordant vs concordant twins       
- All pregnancies 2 (1965)31,45 (21/212 vs 11/1753) 17.4 (8.27-36.7) <0.001 65.6 (46.8-80.8) 90.1 (88.7-91.4)
- Pregnancies ≥34 weeks 1 (1608)31 (12/149 vs 6/1459) 21.2 (7.20-69.7) <0.001 66.7 (41.2-85.6) 91.4 (89.9-92.7)
- Pregnancies <34 weeks 1 (253) 31 (10/58 vs 4/195) 9.95 (2.69-44.8) <0.001 71.4 (42.0-90.4) 80.0 (74.2-84.7) 
- ≥ 1 SGA twin 1 (839)31 (20/187 vs 4/652) 19.4 (6.35-78.4) <0.001 83.3 (61.8-94.5) 79.5 (76.5-82.2) 
- Both AGA twins 1 (1020)31 (1/20 vs 6/1000) 8.72 (0.18-77.1) 0.4 14.3 (0.8-58.0) 98.1 (97.0-98.8) 
       
NND in discordant vs concordant twins       
- All pregnancies 2 (2237)31,47 (3/247 vs 17/1990) 1.42 (0.42-4.90) 0.6 15.0 (4.0-38.9) 89.0 (87.6-90.3) 
- Pregnancies ≥34 weeks 1 (1608) (1/149 vs 5/1459) 1.96 (0.04-17.7) 0.5 16.7 (0.9-63.5) 90.8 (89.5-92.1) 
- Pregnancies <34 weeks 1 (253)31 (2/58 vs 9/195) 0.74 (0.07-3.72) 0.7 18.2 (3.2-52.2) 76.9 (70.9-81.9) 
- ≥ 1 SGA twin 1 (839)31 (3/187 vs 1/652) 10.6 (0.84-558) 0.9 75.0 (21.9-98.7) 78.0 (75.0-80.7) 
- Both AGA twins 1 (1020)31 (0/20 vs 13/1000) 0.0 (0.0-15.0) 0.6 0.0 (0.0-28.3) 98.0 (96.9-98.7) 
       
PND in discordant vs concordant twins       
- All pregnancies 3 (2289)31,37,50 (28/252 vs 30/2037) 8.36 (4.90-14.3) <0.001 48.3 (35.1-61.7) 90.0 (88.6-91.2) 
- Pregnancies ≥34 weeks 1 (1608)31 (2/149 vs 11/1459) 1.79 (0.19-8.32) 0.4 15.4 (2.7-46.3) 90.8 (89.2-92.1) 
- Pregnancies <34 weeks 1 (253)31 (12/58 vs 13/195) 3.65 (1.41-9.27) 0.002 48.0 (28.3-68.2) 79.8 (73.9-84.7) 
- ≥ 1 SGA twin 1 (839)31 (23/187 vs 5/652) 18.1 (6.59-61.8) <0.001 82.1 (62.4-93.2) 79.8 (76.8-82.5) 
- Both AGA twins 1 (1020)31 (1/20 vs 19/1000) 2.72 (0.06-19.0) 0.3 5.0 (0.3-26.9) 98.1 (97.0-98.8) 
 
OR = Odds Ratio;   CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age.   When <2 studies could be included in a meta-analysis, the OR was computed from the 
raw data of the single study. 
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Table 6. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in dichorionic twins 
with birthweight discordance ≥30% (discordant twins) versus dichorionic twins without birthweight discordance (concordant twins), overall and by 
selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
 IUD in discordant vs concordant twins       
- All pregnancies 1 (1859)31 (17/109 vs 14/1750) 22.9 (10.2-51.6) <0.001 54.8 (36.3-72.2) 95.0 (93.8-95.9)
- Pregnancies ≥34 weeks 1 (1608)31 (8/72 vs 9/1536) 21.2 (6.84-63.9) <0.001 47.1 (23.9-71.5) 96.0 (94.9-96.9)
- Pregnancies <34 weeks 1 (253)31 (9/37 vs 5/216) 13.6 (3.70-54.3) <0.001 64.3 (35.6-86.0) 88.3 (83.4-91.9) 
- ≥ 1 SGA twin 1 (903)31 (16/170 vs 7/733) 10.7 (4.07-31.3) <0.001 69.6 (47.0-85.9) 45.0 (39.1-51.0) 
- Both AGA twins 1 (1020)31 (0/3 vs 7/1017) 0.0 (0.0-211) 0.9 0.0 (0.0-43.9) 99.7 (99.1-99.9) 
       
NND in discordant vs concordant twins       
- All pregnancies 1 (1859)31 (3/109 vs 14/1750) 3.51 (0.64-12.8) 0.8 17.6 (4.7-44.2) 94.2 (93.1-95.2) 
- Pregnancies ≥34 weeks 1 (1608)31 (1/72 vs 5/1536) 4.32 (0.09-39.2) 0.15 16.7 (0.9-63.5) 95.6 (94.4-96.5) 
- Pregnancies <34 weeks 1 (253) 31 (2/37 vs 9/216) 13.2 (1.33-66.8) <0.001 18.2 (3.2-52.2) 85.5 (80.3-89.6) 
- ≥ 1 SGA twin 1 (903)31 (3/170 vs 1/733) 13.1 (1.04-691) 0.004 75.0 (21.9-98.7) 81.4 (78.7-83.9) 
- Both AGA twins 1 (1020)31 (0/3 vs 13/1017) 0.0 (0.0-107) 0.8 0.0 (0.0-28.3) 99.7 (99.1-99.9) 
       
PND in discordant vs concordant twins       
- All pregnancies 1 (1859)31 (20/109 vs 28/1750) 13.8 (7.06-26.5) <0.001 41.7 (27.9-56.7) 95.1 (93.7-96.0) 
- Pregnancies ≥34 weeks 1 (1608)31 (9/72 vs 14/1536) 15.5 (5.67-40.0) <0.001 39.1 (20.5-61.2) 96.0 (94.9-96.9) 
- Pregnancies <34 weeks 1 (253)31 (11/37 vs 14/216) 6.41 (2.34-16.9) <0.001 44.0 (25.0-64.7) 88.6 (83.6-92.2) 
- ≥ 1 SGA twin 1 (903)31 (19/170 vs 8/733) 12.2 (4.96-32.8) <0.001 70.4 (49.6-85.5) 82.8 (80.1-85.2) 
- Both AGA twins 1 (1020)31 (0/3 vs 20/1017) 0.0 (0.0-66.9) 0.8 0.0 (0.0-20.0) 99.7 (99.0-99.9) 
OR = Odds Ratio;   CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single 
study. 
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Table 7. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in monochorionic 
twins with birthweight discordance ≥15% (discordant twins) versus monochorionic twins without birthweight discordance (concordant twins), overall 
and by selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
 IUD in discordant vs concordant twins       
- All pregnancies 1 (302)31 (9/103 vs 8/199) 2.29 (0.75-7.02) 0.09 52.9 (28.5-76.1) 67.0 (61.2-72.4) 
- Pregnancies ≥34 weeks 1 (230)31 (4/66 vs 1/164) 10.5 (1.00-521) 0.010 80.0 (29.9-98.9) 72.4 (66.0-78.1) 
- Pregnancies <34 weeks 1 (73)31 (5/37 vs 7/36) 0.65 (0.15-2.69) 0.5 41.7 (16.5-71.4) 47.5 (34.8-60.6) 
- ≥ 1 SGA twin 1 (152)31 (9/79 vs 1/73) 7.97 (1.04-355) 0.02 90.0 (54.1-99.5) 50.7 (42.2-59.1) 
- Both AGA twins 1 (150)31 (0/24 vs 7/126) 0.0 (0.0-2.83) 0.2 0.0 (0.0-43.9) 83.2 (75.9-88.7) 
       
NND in discordant vs concordant twins       
- All pregnancies 1 (302)31 (1/103 vs 1/199) 1.94 (0.02-153) 0.6 50.0 (2.7-97.3) 66.0 (60.3-71.3) 
- Pregnancies ≥34 weeks 1 (230)31 (0/66 vs 0/164) -- -- -- 71.3 (64.9-77.0) 
- Pregnancies <34 weeks 1 (73)31 (1/37 vs 1/36) 0.97 (0.01-78.5) 0.9 50.0 (2.7-97.3) 49.3 (37.3-61.3) 
- ≥ 1 SGA twin 1 (152)31 (1/79 vs 1/73) 0.92 (0.01-73.4) 0.9 50.0 (2.7-97.3) 48.0 (39.8-56.3) 
- Both AGA twins 1 (150)31 (0/24 vs 0/126) -- -- -- 84.0 (76.9-89.3) 
       
PND in discordant vs concordant twins       
- All pregnancies 1 (302)31 (10/103 vs 9/199) 2.26 (0.8-2.5) 0.09 52.6 (28.9-75.6) 67.1 (61.3-72.6-69.2) 
- Pregnancies ≥34 weeks 1 (230)31 (4/66 vs 1/164) 10.5 (1.0-521) 0.010 80.0 (29.9-98.9) 72.4 (66.0-78.1) 
- Pregnancies <34 weeks 1 (73)31 (5/37 vs 7/36) 0.68 (0.17-2-56) 0.5 42.9 (18.8-70.4) 47.5 (34.5-60.8) 
- ≥ 1 SGA twin 1 (152)31 (9/79 vs 1/73) 5.14 (1.03-49.5) 0.02 83.3 (50.9-97.1) 50.7 (42.2-59.2) 
- Both AGA twins 1 (150)31 (0/24 vs 7/126) 0.0 (0.0-2.83) 0.2 0.0 (0.0-43.9) 83.2 (75.9-88.7) 
OR = Odds Ratio;  CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single 
study. 
 
This article is protected by copyright. All rights reserved.
Ac
c
e
p
t
e
d
 
A
r
t
i
c
l
e
 
 
 
Table 8. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in monochorionic 
twins with birthweight discordance ≥20% (discordant twins) versus monochorionic twins without birthweight discordance (concordant twins), overall 
and by selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
IUD in discordant vs concordant twins       
- All pregnancies 6 (1286)29,31,34,39,44,46 (15/323 vs 17/963) 2.75 (1.31-5.76) 0.007 46.9 (29.5-65.0) 75.4 (72.9-77.7)
- Pregnancies ≥34 weeks 3 (676)31,34,44 (7/206 vs 5/470) 3.27 (1.03-10.4) 0.045 58.3 (28.6-83.5) 70.0 (66.4-73.5)
- Pregnancies <34 weeks 3 (411)31,34,48 (5/98 vs 8/313) 0.84 (0.3-2.8) 0.787 38.46 (13.9-78.4) 76.6 (72.2-80.7) 
- ≥ 1 SGA twin 1 (151)31 (7/57 vs 3/94) 4.1 (1.1-17.1) 0.04 70.0 (34.8-93.3) 64.5 (56.1-72.2) 
- Both AGA twins 2 (400)29,31 (1/33 vs 9/367) 1.37 (0.18-10.5) 0.775 10.0 (25.0-44.5) 91.79 (87.6-94.3) 
       
NND in discordant vs concordant twins       
- All pregnancies 5 (659)31,41,43,44,46 (7/237 vs 7/422) 2.00 (0.66-6.10) 0.2 50.0 (24.0-76.0) 64.0 (60.5-68.0) 
- Pregnancies ≥34 weeks 3 (478)31,43,44 (1/167 vs 0/311) 1.86 (0.05-∞)* 0.7 100 (5.5-100) 65.2 (60.7-69.4) 
- Pregnancies <34 weeks 2 (166)31,48 (2/44 vs 3/122) 2.11 (0.3-14.3) 0.8 40.00 (5.3-85.3) 73.91 (66.4-80.5) 
- ≥ 1 SGA twin 2 (194)31,43 (1/65 vs 1/129) 2.00 (0.12-32.5) 0.6 50.0 (2.7-97.3) 66.7 (59.5-73.2) 
- Both AGA twins 2 (192)31,43 (0/17 vs 0/175) -- -- -- 91.1 (86.0-94.6) 
       
PND in discordant vs concordant twins       
- All pregnancies 4 (746)31,36,44,46 (20/251 vs 20/495) 2.27 (1.15-4.48) 0.019 50.0 (34.1-65.9) 67.3 (63.7-70.7) 
- Pregnancies ≥34 weeks 2 (428)31,44 (6/152 vs 4/276) 2.79 (0.78-10.1) 0.12 60.0 (27.4-86.3) 65.1 (60.3-69.6) 
- Pregnancies <34 weeks 2(166)31,48 (7/44 vs 11/122) 1.01 (0.4-3.9) 0.799 38.89 (17.3-64.3) 75.00 /67.2-81.8)
- ≥ 1 SGA twin 1 (151)31 (8/57 vs 4/94) 3.67 (0.92-17.4) 0.3 66.7 (35.4-88.7) 64.7 (56.1-72.5) 
- Both AGA twins 1 (150)31 (0/10 vs 7/140) 0.0 (0.0-7.89) 0.5 0.0 (0.0-43.9) 93.0 (87.2-96.4) 
OR = Odds Ratio;  CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age;    
* Exact logistic regression, as no logistic regression model was possible due to zero event in the reference group.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single study. 
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Table 9. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in monochorionic 
twins with birthweight discordance ≥25% (discordant twins) versus monochorionic twins without birthweight discordance (concordant twins), overall 
and by selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
IUD in discordant vs concordant twins       
- All pregnancies 5 (993)31,35,38,42,45 (11/142 vs 22/851) 3.15 (1.49-6.67) 0.003 33.3 (18.6-51.9) 86.4 (83.9-88.4) 
- Pregnancies ≥34 weeks 2 (405)31,42 (2/47 vs 4/358) 3.95 (0.69-22.7) 0.12 33.3 (6.0-75.9) 88.7 (85.1-91.6) 
- Pregnancies <34 weeks 3 (523)31,38,42 (7/91 vs 13/432) 1.75 (0.64-4.82) 0.3 35.0 (16.3-59.1) 83.3 (79.7-86.4) 
- ≥ 1 SGA twin 3 (393)31,35,45 (8/75 vs 8/318) 4.63 (1.68-12.8) 0.003 50.0 (25.5-74.5) 82.2 (77.9-85.9) 
- Both AGA twins 1 (150)31 (0/1 vs 7/149) 6.33 (0.24-169) 0.3 0.0 (0.0-43.9) 99.3 (95.6-100) 
       
NND in discordant vs concordant twins       
- All pregnancies 6 (1203)31,32,35,38,42,47 (7/182 vs 6/1021) 4.66 (1.8-12.4) 0.002 53.9 (25.1-80.8) 85.3 (83.2-87.3) 
- Pregnancies ≥34 weeks 1 (230)31 (0/22 vs 0/208) -- -- -- 90.4 (85.7-93.8) 
- Pregnancies <34 weeks 2 (348)31,38 (2/66 vs 4/282) 2.17 (0.39-12.1) 0.4 33.3 (6.0-75.9) 81.3 (76.6-85.2) 
- ≥ 1 SGA twin 2 (280)31,35 (3/66 vs 1/214) 10.1 (1.04-99.2) 0.046 75.0 (21.9-98.7) 77.2 (71.7-81.9) 
- Both AGA twins 1 (150)31 (0/1 vs 0/149) -- -- -- 99.3 (95.8-100) 
       
PND in discordant vs concordant twins       
- All pregnancies 5 (1021)31,35,37,38,42 (28/170 vs 44/851) 3.16 (1.87-5.36) <0.001 38.9 (27.8-51.1) 85.0 (82.6-87.2) 
- Pregnancies ≥34 weeks 1 (230)31 (2/22 vs 3/208) 6.83 (0.53-62.4) 0.7 2.2 (0.8-5.3) 40.0 (7.3-82.9) 
- Pregnancies <34 weeks 2 (348)31,37 (6/66 vs 17/282) 1.02 (0.86-2.86) 0.9 26.1 (11.1-48.7) 81.5 (76.8-85.5) 
- ≥ 1 SGA twin 2 (280)31,35 (3/66 vs 1/214) 10.1 (1.04-99.2) 0.046 75.0 (21.9-98.7) 77.2 (71.7-81.9) 
- Both AGA twins 1 (150)31 (0/1 vs 7/149) 6.33 (0.24-169) 0.3 0.0 (0.0-43.9) 99.3 (95.6-100) 
OR = Odds Ratio; CI = Confidence Interval;  SGA = Small for gestational age;   AGA = Appropriate for gestational age; When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single 
study. 
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Table 10. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in monochorionic 
twins with birthweight discordance ≥30% (discordant twins) versus monochorionic twins without birthweight discordance (concordant twins), overall 
and by selected gestational characteristics. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
IUD in discordant vs concordant twins       
- All pregnancies 1 (302)31 (4/29 vs 13/273) 3.20 (0.70-11.4) 0.04 23.5 (7.8-50.2) 91.2 (87.2-94.1) 
- Pregnancies ≥34 weeks 1 (230)31 (2/12 vs 3/218) 14.3 (1.05-136) <0.001 40.0 (7.3-83.0) 95.6 (91.7-97.7) 
- Pregnancies <34 weeks 1 (73)31 (2/17 vs 10/56) 0.61 (0.06-3.40) 0.6 16.7 (2.9-49.1) 75.4 (62.4-85.2) 
- ≥ 1 SGA twin 1 (152)31 (4/28 vs 6/124) 3.28 (0.62-14.9) 0.07 40.0 (13.7-72.6) 83.1 (75.7-88.7) 
- Both AGA twins 1 (150)31 (0/1 vs 7/149) 6.33 (0.24-169) 0.3 0.0 (0.0-43.9) 99.3 (95.6-100) 
       
NND in discordant vs concordant twins       
- All pregnancies 1 (302)31 (0/29 vs 1/273) 3.08 (0.12-77.3) 0.5 0.0 (0.0-94.5) 90.4 (86.3-93.3) 
- Pregnancies ≥34 weeks 1 (230)31 (0/12 vs 0/218) -- -- -- 94.8 (90.8-97.2) 
- Pregnancies <34 weeks 1 (73)31 (0/17 vs 2/56) 0.0 (0.0-6.52) 0.4 0.0 (0.0-80.2) 76.1 (64.2-85.1) 
- ≥ 1 SGA twin 1 (152)31 (0/28 vs 2/124) 0.0 (0.0-8.69) 0.5 0.0 (0.0-80.2) 81.3 (74.0-87.0) 
- Both AGA twins 1 (150)31 (0/1 vs 0/149) -- -- -- 99.3 (95.8-100) 
       
PND in discordant vs concordant twins       
- All pregnancies 1 (302)31 (4/29 vs 14/273) 2.96 (0.66-10.4) 0.06 22.2 (7.4-48.1) 91.2 (87.1-94.1) 
- Pregnancies ≥34 weeks 1 (230)31 (2/12 vs 3/218) 14.3 (1.05-136) <0.001 40.0 (7.3-83.0) 95.6 (91.7-97.7) 
- Pregnancies <34 weeks 1 (73)31 (2/17 vs 12/56) 0.49 (0.05-2.63) 0.4 14.3 (2.5-43.8) 74.6 (61.3-84.6) 
- ≥ 1 SGA twin 1 (152)31 (4/28 vs 8/124) 2.42 (0.49-9.88) 0.16 33.3 (11.3-64.6) 82.6 (75.4-88.5) 
- Both AGA twins 1 (150) 31 (0/1 vs 7/149) 6.33 (0.24-169) 0.3 0.0 (0.0-43.9) 99.3 (95.6-100) 
OR = Odds Ratio;  CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single 
study. 
 
 
This article is protected by copyright. All rights reserved.
Ac
c
e
p
t
e
d
 
A
r
t
i
c
l
e
 
 
 
Table 11. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in smaller (SGA) 
versus larger (AGA) dichorionic twins, stratified by degree of birthweight discordance. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
IUD in SGA vs AGA twins       
Birthweight discordance:       
- ≥15% 1 (1138)31 (25/569 vs 0/569) 53.3 (3.24-878) 0.005 100 (83.4-100) 51.1 (48.2-54.1) 
- ≥20% 4 (2190)29,31,33,44 (28/1095 vs 2/1095) 14.8 (3.51-62.6) <0.001 96.6 (80.4-99.8) 50.6 (48.5-52.8) 
- ≥25% 1 (414) 31 (20/207 vs 1/207) 22.0 (3.44-917) <0.001 95.2 (74.1-99.8) 52.4 (47.3-57.4) 
- ≥30% 1 (218)31 (13/109 vs 1/109) 14.6 (2.10-627) <0.001 92.6 (64.2-99.6) 52.9 (45.8-59.9) 
       
NND in SGA vs AGA twins       
Birthweight discordance:       
- ≥15% 1 (1138)31 (3/569 vs 1/569) 3.01 (0.24-158) 0.3 75.0 (21.9-98.7) 50.1 (47.1-53.0) 
- ≥20% 2 (1838)31,44 (4/919 vs 0/919) 5.30 (0.66--∞)* 0.12 100 (39.6-100) 50.1 (47.8-52.4) 
- ≥25% 1 (414) 31 (3/207 vs 0/207) 7.10 (0.36-138) 0.2 100 (31.0-100) 50.4 (54.4-55.3) 
- ≥30% 1 (218) 31 (3/109 vs 0/109) 7.20 (0.37-141) 0.2 100 (31.0-100) 50.7 (43.8-57.5) 
       
PND in SGA vs AGA twins       
Birthweight discordance:       
- ≥15% 1 (1138)31 (28/569 vs 1/569) 29.4 (4.82-1203) <0.001 96.6 (80.4-99.8) 51.2 (48.2-54.2) 
- ≥20% 2 (1838)31,44 (4/919 vs 0/919) 5.30 (0.66--∞)* 0.12 100 (39.6-100) 50.1 (47.8-52.4) 
- ≥25% 1 (414)31 (23/207 vs 1/207) 25.8 (4.08-1065) <0.001 95.8 (76.9-99.8) 52.8 (47.7-57.8)
- ≥30% 1 (218)31 (17/109 vs 1/109) 19.9 (2.98-841) <0.001 94.4 (70.6-99.7) 54.0 (46.8-61.0) 
 
OR = Odds Ratio; CI = Confidence Interval; SGA = Small for gestational age;   AGA = Appropriate for gestational age.    
* Exact logistic regression, as no logistic regression model was possible due to zero event in the reference group.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single study. 
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Table 12. Pooled odds ratios showing the likelihood of: intrauterine death (IUD), neonatal death (NND) and perinatal death (PND) in smaller (SGA) 
versus larger (AGA) monochorionic twins, stratified by degree of birthweight discordance. 
 
 N. studies 
(sample) 
Fetuses 
(n/N vs n/N) 
Pooled OR 
(95% CI) 
p Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
IUD in SGA vs AGA twins       
Birthweight discordance:       
- ≥15% 1 (206)31 (7/103 vs 2/103) 3.68 (0.67-37.0) 0.09 87.5 (46.7-99.3) 51.5 (44.3-58.6) 
- ≥20% 2 (368)31,44 (8/184 vs 2/184) 3.87 (0.78-19.3) 0.06 80.0 (44.4-97.5) 50.8 (45.5-56.1)
- ≥25% 1 (94)31 (6/47 vs 1/47) 6.73 (0.75-316) 0.8 85.7 (42.0-99.2) 52.9 (41.9-63.6)
- ≥30% 1 (58)31 (3/29 vs 1/29) 3.23 (0.24-175) 0.3 75.0 (21.9-98.7) 51.9 (38.0-65.5) 
       
NND in SGA vs AGA twins       
Birthweight discordance:       
- ≥15% 1 (206)31 (1/103 vs 0/103) 3.03 (0.12-75.2) 0.5 100 (5.5-100) 50.2 (43.2-57.3) 
- ≥20% 3 (422)31,44,46 (5/211 vs 3/211) 1.74 (0.39-7.68) 0.5 62.5 (25.9-89.8) 50.2 (45.3-55.2) 
- ≥25% 2 (188)30,31 (1/94 vs 1/94) 1.0 (0.06-16.2) 0.99 50.0 (2.7-97.3) 50.0 (42.6-57.4) 
- ≥30% 1 (58)31 (0/29 vs 0/29) -- -- -- 50.0 (36.7-63.3) 
       
PND in SGA vs AGA twins       
Birthweight discordance:       
- ≥15% 1 (206)31 (7/103 vs 2/103) 3.68 (0.67-37.0) 0.09 87.5 (46.7-99.3) 51.5 (44.3-58.6) 
- ≥20% 3 (450)31,36,44 (12/225 vs 3/225) 4.19 (1.16-15.1) 0.028 80.0 (51.4-94.7) 51.0 (46.2-55.8) 
- ≥25% 1 (94)31 (6/47 vs 1/47) 6.73 (0.75-316) 0.8 85.7 (42.0-99.2) 52.9 (41.9-63.6) 
- ≥30% 1 (58)31 (3/29 vs 1/29) 3.23 (0.24-175) 0.3 75.0 (21.9-98.7) 51.9 (38.0-65.5) 
OR = Odds Ratio;  CI = Confidence Interval;   SGA = Small for gestational age;   AGA = Appropriate for gestational age.   When <2 studies could be included in a meta-analysis, the OR was computed from the raw data of the single 
study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
This article is protected by copyright. All rights reserved.
Ac
c
e
p
t
e
d
 
A
r
t
i
c
l
e
 
 
Figure Legend 
 
Figure 1. Systematic review flowchart 
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